FDA allows expansion of stem cell trial for ALS

04/18/2013 | Detroit Free Press

The FDA has approved the expansion of a clinical study using human neural stem cells to treat amyotrophic lateral sclerosis. The University of Michigan, Emory University and Neuralstem will take part in the 15-patient midstage trial. Pending approval by an Institutional Review Board, recruitment at Michigan could begin in the summer.

View Full Article in:

Detroit Free Press

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC